• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Urinary incontinence Market

    ID: MRFR/MED/11942-HCR
    100 Pages
    Garvit Vyas
    October 2025

    US Urinary Incontinence Market Research Report By Type (Urge incontinence, Stress Incontinence, Overflow incontinence, Functional incontinence) and By Devices (Electrical Stimulation Devices, Foley Catheters, Antimicrobial Foley Catheters, Urethral Bulking Agents) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Urinary incontinence Market Infographic
    Purchase Options

    US Urinary incontinence Market Summary

    As per MRFR analysis, the US urinary incontinence market size was estimated at 2750.0 USD Million in 2024. The US urinary incontinence market is projected to grow from 2928.75 USD Million in 2025 to 5500.0 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 6.5% during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    The US urinary incontinence market is experiencing notable growth driven by technological advancements and demographic shifts.

    • Technological innovations are enhancing product efficacy and user experience in the urinary incontinence market.
    • Increased awareness and education regarding urinary incontinence are contributing to higher product adoption rates among consumers.
    • The aging population is a significant factor, with older adults representing the largest segment of the market.
    • Rising prevalence of chronic conditions and advancements in product development are key drivers propelling market growth.

    Market Size & Forecast

    2024 Market Size 2750.0 (USD Million)
    2035 Market Size 5500.0 (USD Million)

    Major Players

    Essity (SE), Kimberly-Clark (US), Procter & Gamble (US), Coloplast (DK), B. Braun (DE), Hollister (US), Medtronic (US), SCA Hygiene Products (SE), Attends Healthcare (US)

    US Urinary incontinence Market Trends

    the urinary incontinence market is experiencing notable shifts driven by various factors. Increasing awareness regarding the condition, coupled with a growing emphasis on women's health, appears to be influencing demand for innovative products. Healthcare providers are increasingly recognizing the importance of addressing urinary incontinence, which may lead to enhanced patient education and improved treatment options. Furthermore, advancements in technology are likely to play a crucial role in the development of more effective solutions, potentially transforming the landscape of this market. In addition, the demographic trends indicate a rising prevalence of urinary incontinence among older adults, which could further stimulate market growth. As the population ages, the need for effective management solutions becomes more pressing. This situation may prompt manufacturers to invest in research and development, aiming to create products that cater to the specific needs of this demographic. Overall, the urinary incontinence market seems poised for growth, driven by a combination of awareness, technological advancements, and demographic shifts.

    Technological Innovations

    Recent advancements in technology are reshaping the urinary incontinence market. New products, such as smart devices and wearable technology, are being developed to monitor and manage symptoms more effectively. These innovations may enhance user experience and compliance, potentially leading to better health outcomes.

    Increased Awareness and Education

    There is a growing focus on raising awareness about urinary incontinence, particularly among healthcare professionals and patients. Educational initiatives are likely to improve understanding of the condition, encouraging individuals to seek treatment and explore available options, which may drive market growth.

    Aging Population

    The demographic shift towards an older population is expected to significantly impact the urinary incontinence market. As more individuals age, the prevalence of urinary incontinence is likely to rise, creating a greater demand for effective management solutions tailored to this demographic.

    US Urinary incontinence Market Drivers

    Rising Healthcare Expenditure

    The urinary incontinence market is influenced by the rising healthcare expenditure in the United States. As individuals allocate more resources to healthcare, there is a corresponding increase in spending on products and services related to urinary incontinence. In 2025, healthcare spending is projected to reach $4 trillion, with a notable portion directed towards managing chronic conditions and improving quality of life. This trend suggests that as financial resources become more available, individuals are more likely to invest in solutions for urinary incontinence, thereby driving market growth. The urinary incontinence market stands to benefit from this increased expenditure.

    Increased Focus on Women's Health

    the urinary incontinence market benefits from a heightened focus on women's health issues. As awareness of female-specific health concerns grows, more women are seeking treatment for urinary incontinence, which is often underreported. Recent studies indicate that nearly 25% of women experience urinary incontinence at some point in their lives. This growing recognition is prompting healthcare providers to offer more targeted solutions, including pelvic floor therapy and specialized products. Consequently, the urinary incontinence market is likely to expand as more women become informed about their options and seek assistance for this condition.

    Advancements in Product Development

    Innovations in product development are significantly impacting the urinary incontinence market. Manufacturers are increasingly investing in research and development to create more effective and comfortable products. For instance, the introduction of absorbent pads and wearable devices that monitor bladder activity has transformed the landscape. The market for these products is projected to reach $5 billion by 2026, indicating a robust growth trajectory. These advancements not only enhance user experience but also encourage more individuals to seek solutions for urinary incontinence, thereby expanding the market. As companies continue to innovate, the urinary incontinence market is expected to see a surge in demand.

    Rising Prevalence of Chronic Conditions

    the urinary incontinence market is growing due to the increasing prevalence of chronic conditions such as diabetes and obesity. These conditions are known to contribute to urinary incontinence, leading to a higher demand for related products and services. According to recent data, approximately 30% of adults with diabetes report experiencing some form of urinary incontinence. This trend suggests that as the population ages and chronic conditions become more common, the urinary incontinence market will likely expand. Furthermore, the healthcare system's focus on managing these chronic conditions may lead to increased awareness and treatment options, further driving the market's growth.

    Growing Acceptance of Incontinence Products

    The urinary incontinence market is experiencing a shift in societal attitudes towards incontinence products. There is a growing acceptance of these products, which is encouraging more individuals to seek help. This change is partly due to increased marketing efforts and the normalization of discussions surrounding urinary incontinence. Surveys indicate that nearly 60% of individuals are now more open to using incontinence products than in previous years. This cultural shift is likely to lead to higher sales and greater market penetration, as more people recognize the benefits of using these products. The urinary incontinence market is poised for growth as acceptance continues to rise.

    Market Segment Insights

    By Type: Stress Incontinence (Largest) vs. Mixed Incontinence (Fastest-Growing)

    The US urinary incontinence market exhibits a varied distribution among its segment values, with stress incontinence holding the largest share. It is the most prevalent form of urinary incontinence, particularly among women, driven by factors such as childbirth, aging, and physical exertion. Following stress incontinence, urge incontinence captures a notable portion of the market, characterized by sudden, intense urges to urinate, often leading to involuntary leakage. Overflow and functional incontinence, while present, hold smaller shares of the overall market. Growth trends in the US urinary incontinence market indicate a significant rise in awareness and diagnosis of mixed incontinence, which has emerged as the fastest-growing segment. This increase is fueled by a greater emphasis on women's health and the stigma reduction surrounding incontinence issues. Moreover, advancements in treatment options, such as minimally invasive surgical techniques and emerging therapies, contribute to the expansion of these market segments, enhancing patient outcomes and attracting a broader demographic seeking solutions.

    Stress Incontinence (Dominant) vs. Mixed Incontinence (Emerging)

    Stress incontinence remains the dominant segment in the US urinary incontinence market, primarily affecting women, and is often triggered by activities that increase abdominal pressure, such as laughter, sneezing, or exercise. It is widely acknowledged that pelvic floor weakening plays a pivotal role in this condition, leading to a variety of treatment options ranging from conservative approaches, like pelvic floor exercises, to surgical interventions. On the other hand, mixed incontinence, which is characterized by a combination of stress and urge incontinence symptoms, is gaining traction as an emerging segment. This increasing recognition and understanding of mixed incontinence highlight the need for tailored treatment solutions, further bridging the gap in effective management and meeting the diverse needs of patients.

    By Product: Absorbent Products (Largest) vs. Neuromodulation Devices (Fastest-Growing)

    In the US urinary incontinence market, market share distribution reveals that absorbent products dominate, holding the largest share among all segments. Surgical products and medications also make substantial contributions, while catheters and neuromodulation devices exhibit smaller yet significant portions, with neuromodulation devices emerging attractively within the market landscape. Growth trends indicate a robust rise in demand for neuromodulation devices as they offer innovative treatment options and improved patient outcomes. The increasing prevalence of urinary incontinence among aging populations, coupled with rising awareness and advancements in technology, further drives the expansion of absorbent products and surgical options. Market dynamics suggest that continuous product innovation and enhancement of patient comfort will remain pivotal in steering future growth.

    Absorbent Products (Dominant) vs. Neuromodulation Devices (Emerging)

    Absorbent products represent the dominant category within the US urinary incontinence market, appealing to a broad demographic seeking comfort and reliability. These products, ranging from pads to underwear, address varying severity levels and user preferences. In contrast, neuromodulation devices, while emerging, showcase significant potential for growth due to their unique therapeutic effects on bladder control. They are increasingly recognized for their effectiveness in treating patients who do not respond well to traditional methods. As patient-centric solutions become paramount, these segments highlight diverging strategies in addressing urinary incontinence.

    By End-user: Hospitals (Largest) vs. Home Care Settings (Fastest-Growing)

    In the US urinary incontinence market, the end-user segment is predominantly occupied by hospitals, which hold a significant share due to their extensive resources and capabilities in managing complex cases. Nursing homes follow closely, serving a large population that requires ongoing care for incontinence management. Home care settings are emerging but are gaining traction rapidly as patient preference shifts toward receiving care in a more comfortable, familiar environment. Ambulatory surgical centers represent a smaller yet vital part of the market, primarily catering to outpatient procedures and services. Growth trends in this segment are being driven by increasing awareness of urinary incontinence issues and the stigma reduction around seeking treatment. The shift towards home care settings is spurred by an aging population that prefers personalized care. Additionally, technological advancements, enhanced product offerings, and supportive government policies for home health care are propelling the demand in these segments, particularly in home care settings, which are expected to continue their rapid growth in the coming years.

    Hospitals (Dominant) vs. Home Care Settings (Emerging)

    Hospitals have established themselves as the dominant end-user in the market, providing comprehensive treatment solutions and housing advanced medical technologies. They cater to a wide array of patients, ranging from those with severe incontinence issues to those seeking surgical interventions, leveraging their extensive infrastructure and expertise. On the other hand, home care settings are emerging as a compelling alternative, driven by patient preference for convenience and comfort. These settings enable personalized care plans and foster closer patient-provider relationships, making them an appealing option for managing urinary incontinence. As more healthcare providers see the value in home care, this segment is projected to witness swift growth, challenging hospitals' dominance in the long term.

    By Gender: Female (Largest) vs. Male (Fastest-Growing)

    In the US urinary incontinence market, the female segment holds the largest market share, significantly outpacing the male segment. This dominance is largely attributed to the higher prevalence of urinary incontinence among women, particularly those aged 50 and above. Factors such as childbirth, menopause, and aging contribute to this condition, making women the primary consumers of urinary incontinence products. Meanwhile, the male segment, although smaller, is witnessing rapid growth as awareness increases and more targeted products enter the market. Growth trends indicate that the male segment is becoming a key area of interest for manufacturers, driven by the rising awareness of urinary incontinence issues among men and the stigma surrounding it gradually diminishing. Innovations in product design specifically for men are fueling this growth, leading to increased acceptance and usage. Additionally, targeted marketing strategies and educational campaigns are essential in addressing the unique needs of male consumers, positioning this segment for significant expansion in the coming years.

    Female (Dominant) vs. Male (Emerging)

    The female segment in the US urinary incontinence market remains dominant, characterized by a robust product range that addresses varied needs from light to severe cases. Women benefit from innovations in absorbent products, such as pads and protective underwear, tailored for comfort and discretion. The market for males, however, is emerging, as recent trends highlight a growing recognition of urinary incontinence issues among men. This segment is seeing an increase in specially designed products like male guards and absorbent briefs that cater to male anatomy and lifestyles. These changes, alongside growing consumer education, are gradually altering the landscape, allowing the male segment to carve out its niche with promising growth potential.

    Get more detailed insights about US Urinary incontinence Market

    Key Players and Competitive Insights

    The urinary incontinence market is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and a focus on patient-centric solutions. Key players such as Procter & Gamble (US), Kimberly-Clark (US), and Coloplast (DK) are actively pursuing strategies that emphasize product development and market expansion. Procter & Gamble (US) has been particularly focused on enhancing its product portfolio through innovative designs and materials, which cater to the diverse needs of consumers. Meanwhile, Kimberly-Clark (US) is leveraging its strong brand presence to penetrate emerging markets, thereby broadening its consumer base. Coloplast (DK) appears to be concentrating on digital health solutions, integrating technology into its product offerings to improve user experience and engagement. Collectively, these strategies contribute to a dynamic competitive environment, where differentiation is increasingly driven by innovation and customer engagement.

    In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance efficiency and responsiveness to market demands. The competitive structure of the urinary incontinence market is moderately fragmented, with several key players holding substantial market shares. This fragmentation allows for a variety of product offerings, catering to different consumer preferences and needs. The collective influence of these major players fosters a competitive atmosphere that encourages continuous improvement and innovation.

    In October 2025, Procter & Gamble (US) announced the launch of a new line of eco-friendly incontinence products, which utilize biodegradable materials. This strategic move not only aligns with the growing consumer demand for sustainable products but also positions the company as a leader in environmental responsibility within the market. The introduction of these products is likely to attract environmentally conscious consumers, thereby expanding Procter & Gamble's market share.

    In September 2025, Kimberly-Clark (US) entered into a partnership with a leading telehealth provider to enhance its customer service capabilities. This collaboration aims to provide consumers with better access to information and support regarding incontinence management. By integrating telehealth solutions, Kimberly-Clark (US) is likely to improve customer satisfaction and loyalty, which are critical in a market where consumer trust is paramount.

    In August 2025, Coloplast (DK) launched a digital platform designed to support patients in managing their incontinence more effectively. This platform offers personalized advice and resources, which could significantly enhance patient engagement and adherence to treatment plans. The strategic importance of this initiative lies in its potential to improve health outcomes while simultaneously reinforcing Coloplast's commitment to innovation in patient care.

    As of November 2025, current trends in the urinary incontinence market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) into product development. Strategic alliances are playing a crucial role in shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is expected to evolve from traditional price-based competition to a focus on innovation, technology, and supply chain reliability. This shift underscores the importance of adapting to consumer preferences and market demands in a rapidly changing environment.

    Key Companies in the US Urinary incontinence Market market include

    Industry Developments

    In recent months, the US Urinary Incontinence Market has witnessed notable developments, driven by increased awareness and shifting demographics. Companies such as UroLift and Boston Scientific are launching innovative treatment options that offer minimally invasive solutions, contributing to enhanced patient satisfaction. In August 2023, Hollister Incorporated announced an expansion of its product line focused on urinary management, demonstrating a commitment to improving quality of life for patients.

    Significant growth has been noted in the market valuation of firms, especially as awareness surrounding urinary incontinence increases and more people seek treatment, highlighting a market growth trend that reflects a projected CAGR over the coming years. In terms of mergers, in September 2023, Convatec successfully acquired a smaller competitor, further strengthening its position in the urinary care segment.

    Furthermore, the ongoing research and development initiatives by Astellas Pharma and Medtronic continue to add to the landscape of available treatment options aiming to address urinary incontinence. The US market is also seeing a rise in telehealth consultations, facilitating broader access to care. Overall, the market is evolving rapidly, marked by innovation, strategic partnerships, and increased consumer demand for reliable treatment options.

    Future Outlook

    US Urinary incontinence Market Future Outlook

    The urinary incontinence market is projected to grow at a 6.5% CAGR from 2024 to 2035, driven by increasing awareness, aging population, and advancements in product technology.

    New opportunities lie in:

    • Development of subscription-based delivery services for incontinence products.
    • Investment in telehealth solutions for remote patient monitoring.
    • Expansion of product lines targeting specific demographics, such as men and postpartum women.

    By 2035, the urinary incontinence market is projected to achieve substantial growth and innovation.

    Market Segmentation

    US Urinary incontinence Market Type Outlook

    • Stress Incontinence
    • Urge Incontinence
    • Overflow Incontinence
    • Functional Incontinence
    • Mixed Incontinence

    US Urinary incontinence Market Gender Outlook

    • Female
    • Male

    US Urinary incontinence Market Product Outlook

    • Absorbent Products
    • Surgical Products
    • Medications
    • Neuromodulation Devices
    • Catheters

    US Urinary incontinence Market End-user Outlook

    • Hospitals
    • Nursing Homes
    • Home Care Settings
    • Ambulatory Surgical Centers

    Report Scope

    MARKET SIZE 2024 2750.0(USD Million)
    MARKET SIZE 2025 2928.75(USD Million)
    MARKET SIZE 2035 5500.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 6.5% (2024 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2019 - 2024
    Market Forecast Units USD Million
    Key Companies Profiled Essity (SE), Kimberly-Clark (US), Procter & Gamble (US), Coloplast (DK), B. Braun (DE), Hollister (US), Medtronic (US), SCA Hygiene Products (SE), Attends Healthcare (US)
    Segments Covered Type, Product, End-user, Gender
    Key Market Opportunities Advancements in wearable technology enhance management solutions in the urinary incontinence market.
    Key Market Dynamics Rising demand for innovative products drives competition and influences regulatory standards in the urinary incontinence market.
    Countries Covered US

    Leave a Comment

    FAQs

    What is the expected market size of the US Urinary Incontinence Market in 2024?

    The expected market size of the US Urinary Incontinence Market in 2024 is valued at 2.9 billion USD.

    What will be the projected market value of the US Urinary Incontinence Market by 2035?

    The projected market value of the US Urinary Incontinence Market by 2035 is anticipated to reach 5.8 billion USD.

    What is the expected compound annual growth rate (CAGR) for the US Urinary Incontinence Market from 2025 to 2035?

    The expected CAGR for the US Urinary Incontinence Market from 2025 to 2035 is 6.504%.

    Which segment holds the largest share within the US Urinary Incontinence Market?

    Urge incontinence is projected to hold a significant share of the US Urinary Incontinence Market, valued at 0.744 billion USD in 2024.

    What is the market value of stress incontinence in the US Urinary Incontinence Market for 2024?

    The market value for stress incontinence in the US Urinary Incontinence Market is forecasted to be 0.892 billion USD in 2024.

    What are the key players operating in the US Urinary Incontinence Market?

    Key players in the US Urinary Incontinence Market include UroLift, Johnson and Johnson, Coloplast, and Medtronic among others.

    What is the anticipated market value for functional incontinence by 2035?

    The anticipated market value for functional incontinence in the US Urinary Incontinence Market is expected to reach 1.338 billion USD by 2035.

    How much is the overflow incontinence segment expected to be valued in 2035?

    The overflow incontinence segment is expected to be valued at 1.19 billion USD in 2035.

    What emerging trends are influencing the US Urinary Incontinence Market?

    Emerging trends in the US Urinary Incontinence Market include advancements in minimally invasive procedures and increased awareness about treatment options.

    What are the main growth drivers for the US Urinary Incontinence Market?

    Key growth drivers for the US Urinary Incontinence Market include the rising aging population and increased prevalence of urinary incontinence disorders.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions